Journal of Pain & Relief
Open Access

Jan MK Hesselink

Institute for Neuropathic Pain, Spoorlaan, MV Bosch en Duin, The Netherlands

Biography

Jan M Keppel Hesselink  currently working as a consultant in Biotech and Pharmaceuticals and R&D advice within the field of drug development in CNS indications.Pain physician and director at the Institute for Neuropathic. He wrote a number of books in the field of neurology and many book chapters, and published extensively in the fields of neurology, neuropathy, pharmacology, CNS, pharmaceutical medicine, drug development, R&D, pharmacotherapy, pain, analgesia, transdermal and topical treatments. His current focus is on drug development and drug repurposing.

Publications

Topical Phenytoin in Neuralgic Pain, Peripheral Modulation of Central Sensitization: Two Case Reports

We herewith describe a topical formulation of phenytoin with a clear analgesic effect in localized neuropathic pain: in post herpetic neuralgia and trigeminal neuralgia. Such topical analgesic effect for phenytoin has not yet been described in literature. We have developed various topical phenytoin formulations and identified a stable cream base in... Read More»

Jan MK Hesselink and David J Kopsky

Case Report: J Pain Relief 2016, 6:284

DOI: 10.4172/2167-0846.1000284

Abstract Peer-reviewed Full Article Peer-reviewed Article PDF Mobile Full Article